Global vaccinespecialist Fort Dodge has become the first manufacturer to develop acombination vaccine to protect sheep and cattle against both BluetongueSerotypes 1 and 8.
The development of the new vaccine was triggered by recent outbreaks of both serotypes of the disease in the same area of France and Spain.
The company said that the bluetongue serotypes 1 and 8 restriction zones are overlapping more and more as serotype 1 moves rapidly further north and serotype 8 moves south. Fort Dodge has obtained a provisional licence for the use of combination vaccines Zulvac 1+8 Bovis and Zulvac 1+8 Ovis vaccine in Spain.
The first deliveries are underway with further supply of the vaccines expected over the next few months. The combination vaccines are produced at its manufacturing plant in Olot, Spain.
Marc Snacken, business manager livestock, Fort Dodge Europe, Africa and Middle East, said: “The new situation where bluetongue serotypes are mixing has created a difficult situation for farmers as mono-valent vaccines provide no cross-protection against other serotypes.
“As a leader in the single serotype vaccine market, we were well placed to start work immediately on a combination vaccine and we are delighted that the dossiers for both the sheep and cattle versions have now been submitted in Spain.
“The new combination vaccine will offer vets and farmers a further tool in the fight against this dreadful disease and will enable them to plan their vaccination campaigns more effectively.”